If enacted, this bill would update current statutes by appropriating $5,000,000 from the state General Fund for fiscal year 2025-2026 to the Department of Health Services (DHS) specifically for conducting a certified clinical research study on the use of ibogaine for treating neurological diseases, including traumatic brain injury and post-traumatic stress disorder. The bill stipulates that grants can only be awarded to entities that meet specific criteria, such as having a proven history in neurological research, possessing the necessary clinical and research facilities, and demonstrating a commitment to securing matching funds of at least $5,000,000 from non-state sources.

Additionally, the bill includes a provision that exempts the appropriation from lapsing, ensuring that the allocated funds remain available for the intended purpose without being subject to the usual lapsing provisions outlined in current law. This change aims to facilitate ongoing research and innovation in the treatment of neurological conditions, thereby enhancing the state's capacity to address these health issues effectively.